Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer

Thursday, March 30, 2023 1 min read

Key Takeaway: Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer

Full Press Release Details

Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer.